Close

 NY-ESO-1

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

  • TriCAR Vector Products

  • TCR-Like CAR

Loading...
  • Target Species:
  • TCR Clone:
  • Epitope:
  • Allele:
  • Vector Type:
CAT Product Name Target Species TCR Clone Epitope Allele Vector Type Inquiry & Datasheet
TriCAR-Z056 Anti- NY-ESO-1(SLLMWITQV)/ HLA-A*0201 TriCAR (T1) (scFv-Sushi Domain-CD28-CD3ζ-PP2A-IL15-Anti-PD-L1), pCDCAR1 Human T1 SLLMWITQV HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
TriCAR-Z057 Anti- NY-ESO-1(SLLMWITQV)/ HLA-A*0201 TriCAR (T2) (scFv-Sushi Domain-CD28-CD3ζ-PP2A-IL15-Anti-PD-L1), pCDCAR1 Human T2 SLLMWITQV HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
TriCAR-Z058 Anti- NY-ESO-1(SLLMWITQV)/ HLA-A*0201 TriCAR (T3) (scFv-Sushi Domain-CD28-CD3ζ-PP2A-IL15-Anti-PD-L1), pCDCAR1 Human T3 SLLMWITQV HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
TriCAR-Z116 Anti- NY-ESO-1(SLLMWITQV)/ HLA-A*0201 TriCAR (T1) (scFv-Sushi Domain-4-1BB-CD3ζ-PP2A-IL15-Anti-PD-L1), pCDCAR1 Human T1 SLLMWITQV HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
TriCAR-Z117 Anti- NY-ESO-1(SLLMWITQV)/ HLA-A*0201 TriCAR (T2) (scFv-Sushi Domain-4-1BB-CD3ζ-PP2A-IL15-Anti-PD-L1), pCDCAR1 Human T2 SLLMWITQV HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
TriCAR-Z118 Anti- NY-ESO-1(SLLMWITQV)/ HLA-A*0201 TriCAR (T3) (scFv-Sushi Domain-4-1BB-CD3ζ-PP2A-IL15-Anti-PD-L1), pCDCAR1 Human T3 SLLMWITQV HLA-A*0201 Lentiviral vector   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.